ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
From - Laboratory Industry Report
Theranos continues to remake itself, shedding its longtime president and expanding its board of directors…
From - Laboratory Industry Report
A new coalition has been formed to push for more laboratory-based allergy testing. The Coalition for Equal Access to Allergy Testing (CEAAT) said it…